Fine tune control (enough for enhanced energy supply but not too much to avoid host cell death) of these mechanisms might be essential for efficient viral infection, thus suggesting that pharmacological modulation of Sig-1R offers here a therapeutic opportunity to counteract the virus program (Figure 3). The gene discussed is SIGMAR1; the disease is viral infectious disease.